Hansa Biopharma up 51% since the CEO's purchase
- Insider
- Renée Aguiar Lucander
- Role
- Chief executive (VD)
- Company
- Hansa Biopharma (HNSA)
- Transaction
- Buy
- Shares
- 47,000
- Amount
- SEK 1.5M
- Price per share
- SEK 31.98
- Trade date
- Sep 25, 2026
- Filed
- Sep 28, 2026, 3 days after the trade
- Source
- Finansinspektionen ↗
Hansa Biopharma CEO Renée Aguiar Lucander bought 47,000 shares at SEK 31.98 on Sep 25, 2026. The stock traded at SEK 50.65 on November 16, 2026, 51.2% above the first close after the purchase.
The purchase totaled SEK 1.5M and was reported to Finansinspektionen on September 28, 2026, 3 days after the trade. No sales by Renée Aguiar Lucander in Hansa Biopharma have been reported since.
Before 2026-09-28, 4 holders had disclosed net short positions in Hansa Biopharma, together 2.64%; the largest, ActusRayPartners Limited, held 0.9%. The price of SEK 50.65 was recorded at 12:38 CET, delayed by 15 to 20 minutes.
HNSA +6.1% on the day, delayed quote Nov 16
Since purchase+51.2%SEK 33.50 → SEK 50.65 at 12:38 CET
Since filing+55.8%SEK 32.50 on Sep 29 → SEK 50.65
PurchaseSEK 1.5M47,000 shares on Sep 25, 2026
Days since purchase52No sales by this filer since
Price since the purchase
Daily close · SEK+50%
0%
Sep 28 · first close 33.50 SEKNov 16 · 50.65 SEK
PurchaseFirst close above +50%